Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
---|---|---|---|---|
Total Revenue | 19,647 | 1,082 | 1,213 | 399 |
Cost of Revenue | -- | -- | (33,084) | -- |
Gross Profit | 19,647 | 1,082 | 1,213 | 399 |
Operating Expenses | ||||
Research Development | 4,668 | (5,531) | 7,007 | 6,118 |
Selling General and Administrative | 1,310 | -- | 1,626 | 1,693 |
Non Recurring | -- | -- | -- | -- |
Others | 0 | (1,814) | 0 | 0 |
Total Operating Expenses | 5,978 | (7,345) | 8,633 | 7,811 |
Operating Income or Loss | 13,669 | 6,613 | (7,420) | (7,412) |
Income from Continuing Operations | ||||
Total Other Income/Expenses Net | (26) | (25) | (25) | (23) |
Earnings Before Interest And Taxes | 13,698 | 6,665 | (7,395) | (7,389) |
Interest Expense | -- | -- | -- | -- |
Income Before Tax | 13,698 | 6,665 | (7,249) | (7,416) |
Income Tax Expense | -- | -- | (435) | -- |
Minority Interest | -- | -- | -- | -- |
Net Income From Continuing Ops | 12,144 | 6,665 | (6,387) | (8,239) |
Non-recurring Events | ||||
Discontinued Operations | -- | -- | -- | -- |
Extraordinary Items | -- | -- | -- | -- |
Effect Of Accounting Changes | -- | -- | -- | -- |
Other Items | 0 | 0 | 0 | 0 |
Net Income | 12,144 | 6,665 | (6,387) | (8,239) |
Preferred Stock And Other Adjustments | 1,554 | 605 | -- | -- |
Net Income Applicable To Common Shares | 12,144 | 6,060 | (6,387) | (8,239) |